AbbVie Inc. (NYSE:ABBV) is one of the 10 Best Major Stocks to Buy According to Wall Street Analysts. Based on a report released on April 10, RBC Capital analyst Trung Huynh maintained a Buy rating on AbbVie Inc. (NYSE:ABBV) while also keeping the firm’s price target of $260. The firm’s price target is slightly higher than the median Wall Street analysts’ price target of $259.
AbbVie Inc. (NYSE:ABBV) is one of the 10 Best Major Stocks to Buy According to Wall Street Analysts.
As CBS News reported on April 7, AbbVie Inc. (NYSE:ABBV) and Roche, through their Genentech Unit, have joined TrumpRx. TrumpRx is a government-run platform that sells medicines directly to consumers at discounted prices. With this move, they become the 10th and 11th drug makers on the platform. AbbVie Inc. (NYSE:ABBV) will provide its arthritis drug Humira at an 86% discount under a pricing agreement with the U.S. government. Genentech has also agreed to sell its flu drug Xofluza for $50, significantly lower than its usual price of $168. The total number of medicines available on TrumpRx has increased to 61, up from about 40 when the platform launched earlier this year.
According to CNN’s compilation, AbbVie Inc. (NYSE:ABBV) is currently covered by 33 Wall Street analysts and has a consensus Buy rating. Analyst estimates suggest the stock could rise as high as $328, implying more than 58% upside from current levels.
AbbVie Inc. (NYSE:ABBV) operates as a biopharmaceutical company. It is involved in the development, commercialization, manufacturing, and sale of medicines and therapies. The company provides Skyrizi, Rinvoq, Imbruvica, Elahere, Venclexta, Epkinly, and Emrelis.
While we acknowledge the potential of ABBV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 10 Companies That Partnered With Nvidia in 2026 and 10 Stocks That Will Skyrocket When Oil Prices Fall.
Disclosure: None. Follow Insider Monkey on Google News.